PCDHGA10 activators refer to a class of chemical compounds that specifically target and increase the expression or functional activity of the protocadherin gamma A10 (PCDHGA10) protein. PCDHGA10 is one of the many cadherin-related neuronal receptors that play a critical role in the establishment of specific cell-cell connections in the nervous system. The mechanisms by which PCDHGA10 activators exert their action can be diverse, ranging from direct interaction with the promoter regions of the PCDHGA10 gene to modulating the cellular signaling pathways that control its transcription and translation. These activators could potentially influence the epigenetic state of the gene, alter the stability of its mRNA, or affect the post-translational modifications that regulate the protein's activity. The chemical compounds classified as PCDHGA10 activators would be expected to have a high degree of specificity, ensuring that they preferentially modulate PCDHGA10 without significantly affecting other members of the protocadherin family or off-target genes.
The study and development of PCDHGA10 activators would involve intricate knowledge of molecular genetics and neurobiology, as well as advanced techniques in chemical synthesis and bioinformatics. Researchers interested in these compounds would likely be focused on unraveling the complex network of intracellular and extracellular factors that regulate PCDHGA10. This would include understanding the cell-type specific expression patterns of PCDHGA10 and how intracellular second messengers convey extracellular signals to the nuclear machinery governing gene expression. Such activators might be used as molecular tools to dissect the role of PCDHGA10 in neuronal development and the maintenance of neural circuits. Furthermore, PCDHGA10 activators could contribute valuable insights into the general principles of cell adhesion and the molecular basis of cell-cell recognition in the nervous system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Influences gene expression through retinoic acid receptors, which could include PCDHGA10. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences Wnt signaling pathway, potentially affecting expression of developmental genes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase, possibly affecting cAMP pathway and gene expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
As a hormone, it can modulate gene expression through estrogen receptors, potentially affecting PCDHGA10. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Mimics cAMP and potentially affects pathways that regulate gene expression, including PCDHGA10. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that may lead to chromatin remodeling, influencing gene expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK and may impact downstream signaling, potentially affecting gene expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibitor of ALK5, possibly affecting TGF-beta signaling and related gene expression. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, may affect cytoskeletal dynamics and potentially influence gene expression. | ||||||